← Evidence map

RetractedArticleClinical hemorheology and microcirculation2024

In vitro simulation of the liver first-pass effect with biotransformation-competent HepG2 cells to study effects of MG-132 on liver and cancer cells.

Sarah Kammerer et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37638428